Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
While research exists on the pH stability and activity of the HIV-1 protease enzyme, this information does not directly apply to the specific stability profile of S-HIV-1 Oligopeptide-3 SP as a cosmetic ingredient. Therefore, its optimal pH range and stability in cosmetic formulations remain undefined.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has not conducted a safety assessment for S-HIV-1 Oligopeptide-3 SP. Pertinent FDA approvals identified in research are exclusively for HIV diagnostic tools or therapeutic protease inhibitors, not for cosmetic applications. Consequently, a comprehensive safety profile specifically for its use in skincare is currently absent.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to a lack of clinical studies, a defined mechanism of action, and comprehensive safety assessments for cosmetic use, the utility and safety of S-HIV-1 Oligopeptide-3 SP as a skincare ingredient cannot be definitively established.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources